Seer, Inc. financial data

Symbol
SEER on Nasdaq
Industry
Laboratory Analytical Instruments
Location
3800 Bridge Parkway, Suite 102, Redwood City, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Seer Biosciences, Inc. (to 1/4/2018)
Latest financial report
10-K - Q4 2024 - Mar 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.92K % -26%
Quick Ratio 46.6 % +40.3%
Debt-to-equity 11.1 % +13.9%
Return On Equity -24.4 % -16.9%
Return On Assets -21.9 % -15.4%
Operating Margin -706 % -13.8%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 64M shares +2.14%
Entity Public Float 95.8M USD -58.7%
Weighted Average Number of Shares Outstanding, Basic 61.2M shares -4.29%
Weighted Average Number of Shares Outstanding, Diluted 61.2M shares -4.29%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 14.2M USD -15%
Cost of Revenue 7.12M USD -12.8%
Research and Development Expense 50.6M USD -4.59%
General and Administrative Expense 14.8M USD -4.39%
Operating Income (Loss) -100M USD +3.25%
Nonoperating Income (Expense) 13.6M USD -20.9%
Net Income (Loss) Attributable to Parent -86.6M USD -0.37%
Earnings Per Share, Basic -1.29 USD/shares +10.4%
Earnings Per Share, Diluted -1.29 USD/shares +10.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 40.8M USD +25.4%
Cash, Cash Equivalents, and Short-term Investments 300M USD -19.7%
Accounts Receivable, after Allowance for Credit Loss, Current 4.83M USD +12%
Inventory, Net 7.44M USD +65.6%
Assets, Current 253M USD -23.4%
Property, Plant and Equipment, Net 18.6M USD -16.3%
Operating Lease, Right-of-Use Asset 22.8M USD -9.48%
Other Assets, Noncurrent 8.28M USD +725%
Assets 367M USD -16%
Accrued Liabilities, Current 7.94M USD -13.8%
Contract with Customer, Liability, Current 408K USD +98.1%
Liabilities, Current 15.3M USD +15.9%
Operating Lease, Liability, Noncurrent 23.7M USD -8.91%
Other Liabilities, Noncurrent 48K USD -73.2%
Liabilities 39M USD -0.86%
Accumulated Other Comprehensive Income (Loss), Net of Tax 136K USD
Retained Earnings (Accumulated Deficit) -392M USD -28.3%
Stockholders' Equity Attributable to Parent 328M USD -17.5%
Liabilities and Equity 367M USD -16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.5M USD +45.9%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 32.4M USD +123%
Common Stock, Shares Authorized 105M shares 0%
Common Stock, Shares, Issued 64M shares +2.14%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 21.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 41.3M USD +25%
Deferred Tax Assets, Valuation Allowance 91.2M USD +23.2%
Deferred Tax Assets, Gross 97.3M USD +20.1%
Operating Lease, Liability 26M USD -8.12%
Depreciation 6.2M USD +10.7%
Payments to Acquire Property, Plant, and Equipment 754K USD +523%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -86.3M USD -1.24%
Lessee, Operating Lease, Liability, to be Paid 32.9M USD -10.8%
Property, Plant and Equipment, Gross 35.4M USD +1.89%
Operating Lease, Liability, Current 2.31M USD +0.74%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.96M USD +2.89%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.85M USD -3.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.98M USD -19.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.07M USD +2.91%
Deferred Tax Assets, Operating Loss Carryforwards 50.6M USD +22.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 3.14M USD +32.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.19M USD +2.92%
Operating Lease, Payments 1.01M USD +2.65%
Additional Paid in Capital 720M USD +2.41%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 28.2M USD -18.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%